Biote (BTMD) Cash from Financing Activities (2021 - 2026)

Biote's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at -$21.5 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 854.32% year-over-year to -$21.5 million; the TTM figure through Mar 2026 stood at -$62.8 million (up 13.84% YoY), while the FY2025 annual figure was -$43.6 million, up 42.75% from the prior year.
• Cash from Financing Activities was -$21.5 million for Q1 2026 at Biote, down from -$9.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $84.3 million in Q2 2022 to a low of -$59.0 million in Q2 2024.
• Historically, Cash from Financing Activities has averaged -$5.4 million across 5 years, with a median of -$5.1 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 125.57% in 2022, then tumbled 1065.92% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$4.0 million in 2022, then jumped by 36.49% to -$2.5 million in 2023, then tumbled by 293.43% to -$9.9 million in 2024, then gained by 8.08% to -$9.1 million in 2025, then plunged by 135.89% to -$21.5 million in 2026.
• The last three Cash from Financing Activities figures came in at -$21.5 million (Q1 2026), -$9.1 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.